Showing results (241-250 of 251) with videos related to

Sort By:
Pageof 26
International Journal of Clinical Oncology|May 9, 2024
The efficacy and safety of anamorelin among patients with diabetesKenju Ando, Tateaki Naito, Satoshi Hamauchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2017
Alectinib for Patients with ALK Rearrangement-Positive Non-Small Cell Lung Cancer and a Poor Performance Status (Lung Oncology Group in Kyushu 1401)Eiji Iwama, Yasushi Goto, Haruyasu Murakami, et al.
BMC Cancer|November 30, 2017
Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational studyTateaki Naito, Taro Okayama, Takashi Aoyama, et al.
BMC Cancer|August 27, 2017
Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancerTateaki Naito, Taro Okayama, Takashi Aoyama, et al.
The Lancet. Oncology|March 28, 2024
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trialEgbert F Smit, Enriqueta Felip, Dipesh Uprety, et al.
Cancer Science|July 5, 2018
Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutationsHaruyasu Murakami, Hiroshi Nokihara, Hidetoshi Hayashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2025
Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non-Small Cell Lung Cancer After Platinum-Based Chemotherapy and ImmunotherapyConor E Steuer, Hidetoshi Hayashi, Wu-Chou Su, et al.
Cancer Discovery|September 22, 2021
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung CancerPasi A Jänne, Christina Baik, Wu-Chou Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2024
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung CancerDaniel Morgensztern, Neal Ready, Melissa L Johnson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 12, 2024
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of GedatolisibShigeki Umemura, Hibiki Udagawa, Takaya Ikeda, et al.
Pageof 26